Silverarc Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.08M Buy
2024
Q2
Sell
2024
Q1
$5.98M Buy
2023
Q4
Sell
2023
Q3
$6.54M Buy
2023
Q1
Sell
2022
Q4
$2.8M Buy
2022
Q3
$2.93M Buy
2022
Q2
$2.6M Buy
2022
Q1
$2.5K Buy
2021
Q4
$3.18M Buy
2021
Q3
$1.04M Buy